There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Last updated:
13 September 2023
Lobbying Register Annual Report 2023
This table sets out sectors with more than 1,000 substantive information returns published. T H E S C O T T I S H PA R L I A M E N T | L O B B Y I N G R E G I S T E R A N N U A L R E P O R T 2 0 2 3 18 This table sets out sectors with less than 1,000 substantive information returns published.T H E S C O T T I S H PA R L I A M E N T | L O B B Y I N G R E G I S T E R A N N U A L R E P O R T 2 0 2 3 19 Information returns process Key Dates The Act sets out what is ‘regulated lobbying’.
SPICe briefings
Date published:
7 September 2017
What's so important about health policy implementation? - 2.2 Human Resources and Training
Journal of School Health, 84(9), 581-585.20J, L.L., M, W., T, W., & P, N. (2009).
Last updated:
25 May 2022
SPBill15FMS062022accessible
The table below shows the development costs from discovery through to implementation, broken down as follows— Capital Resource Total 2021-22 £0.9 m £0 m £0.9 m 2022-23 £3.1 m £0 m £3.1 m 2023-24 £3.4 m £0.1 m £3.5 m 2024-25 £0.8 m £0.1 m £0.9 m Total £8.2 m £0.2 m £8.4 m 7 This document relates to the Moveable Transactions (Scotland) Bill (SP Bill 15) as introduced in the Scottish Parliament on 25 May 2022 38.
Last updated:
7 March 2023
BB20201111
Supported by: Graeme Dey*, Mairi Gougeon* *S5M-23312 Jeane Freeman: Medicines and Medical Devices Bill - UK Legislation—That the Parliament agrees that the relevant provisions of the Medicines and Medical Devices Bill, introduced into the House of Commons on 13 February 2020, relating to information systems, so far a...
SPICe briefings
Date published:
26 January 2026
Promoting Healthy Ageing in Scotland - GLP-1 medicines
Current barriers to the widespread adoption of GLP-1 medicines include the cost and availability of medicines across the UK.
Committee reports
Date published:
30 June 2020
Supply and demand for medicines - Executive Summary
The lack of data collection and analysis on outcomes achieved via the prescriptions of medicines is of huge concern. The impact on individual patients of taking medicines is not being examined and worse, it is not routinely sought.
Committee reports
Date published:
30 June 2020
Supply and demand for medicines - Changes since the Montgomery Review - Clinical and cost effectiveness of new medicines
Changes since the Montgomery Review - Clinical and cost effectiveness of new medicines
While recognising the welcome outcome of increased access to new medicines as a result of changes implemented since the Review of Access to New Medicines, we were disappointed to hear some ...
Last updated:
19 June 2023
Milton Session
M alerted her mum by text, who then contacted the shopping centre security to beg them to prevent any attack until M’s dad could arrive.
Committee reports
Date published:
30 June 2020
Supply and demand for medicines - Prescribing non-licensed medicines
Prescribing non-licensed medicines
We were interested in prescriptions for unlicensed medicines.
Last updated:
10 June 2024
Financial Memorandum Children (Scotland) Bill
Table 12: estimated set up costs Set up costs 2022/23 Staff costs (£m) 0.06 Accommodation costs (£m) 0.01 IT costs (£m) 0.01 Training costs (£m) 0.01 Total costs (£m) 0.09 61.
